Euro-BioImaging is organizing an online User Forum on October 6, 2022, from 14:00-17:00 CEST. This event will highlight the importance of cutting-edge imaging technologies in support of fighting infectious diseases and showcase the specific expertise available at our Nodes across Europe through case studies presented in tandem with the research community.
At this event, Hanna Renvall, Aalto University, will speak about recent steps towards novel clinical applications of MEG, including recently launched EU Horizon 2020 project Long COVID on the mechanisms and biomarkers of long-term effects of COVID-19 infection, undertaken in collaboration with the Finnish Biomedical Imaging Node (full abstract below).
Noninvasive neuroimaging methods that are based on detecting changes in neural currents (magnetoencephalography, MEG; electroencephalography, EEG) offer efficient means for identifying alterations in brain function beyond structural changes. Especially MEG, with its good temporal and spatial resolution, provides a unique possibility among neuroimaging methods to characterise global cortical networks in both health and disease. In this talk, I will describe recent steps towards novel clinical applications of MEG, including recently launched EU Horizon 2020 project Long COVID on the mechanisms and biomarkers of long-term effects of COVID-19 infection.
More news from Euro-BioImaging
March 19, 2026
France BioImaging Annual Meeting 2026 highlights leadership, collaboration and scientific excellence
The 2026 Annual Meeting of France BioImaging, held on 12–13 March at the University of Rouen Normandie, brought together node leaders, facility staff, industry…
EVOLVE Distributed In-Person Training Course: Intro to BioImaging Analysis with Python for Life Scientists
After a very successful first edition, Euro-BioImaging is proud to announce the second edition of the distributed training course for “Intro to BioImage Analysis…